Behavioral Disciplines and Activities
Medical Center Mentalcare Ltd. conducts research aimed at improving the treatment of anxiety and depressive disorders. Trials explore new adjunctive therapies and novel drug candidates for Generalized Anxiety Disorder and Major Depressive Disorder, seeking better symptom control and relapse prevention.
- Adjunctive therapy for treatment‑resistant depression
- Monotherapy approaches for generalized anxiety
- Evaluation of relapse‑prevention strategies
- Safety and tolerability assessments of new psychiatric agents
The site’s ongoing work aims to expand therapeutic options for patients with mood and anxiety disorders, with the hope of enhancing quality of life.
Mental Disorders
In the field of mental disorders, the center focuses on schizophrenia and severe mood conditions. Studies assess the impact of innovative adjunctive medications and target symptom reduction in Schizophrenia and complex depressive presentations.
- Adjunctive treatment for inadequately controlled schizophrenia
- Assessment of novel antipsychotic agents
- Long‑term safety monitoring of psychiatric drugs
- Combination strategies for severe depressive symptoms
Through these investigations, Medical Center Mentalcare Ltd. contributes to advancing care for individuals living with serious mental illnesses.
